Navigation Links
Jobson Medical Information LLC Acquires CenterWatch and New England IRB From Thomson Healthcare
Date:1/8/2008

NEW YORK, Jan. 8 /PRNewswire/ -- Jobson Medical Information LLC ("JMI"), a leading healthcare information and marketing services provider, announced that they had acquired the assets of CenterWatch and The New England Institutional Review Board ("NEIRB") from Thomson Healthcare Inc., a subsidiary of the Thomson Corporation. Terms of the transaction were not disclosed.

CenterWatch and NEIRB provide information and services that support the efficient execution of clinical trials. Founded in 1994, CenterWatch is a publishing and information services company supplying critical data to the clinical trials industry. Key customers include pharmaceutical companies, biotechnology and medical device companies, CRO's and patients involved in clinical trials. The CenterWatch website lists over 5,000 clinical trials and details of over 30,000 clinical trial sites. The website attracts over 200,000 visitors per month.

NEIRB provides FDA mandated services to pharmaceutical companies and CRO's. Founded in 1988, NEIRB was one of the first central institutional review boards established to meet the ethical review needs of a burgeoning drug development market.

"Both CenterWatch and NEIRB expand our presence in the development stage of the pharmaceutical product pipeline. Allied with our Medical Intelligence Solutions business we are developing significant scale in clinical trial information services," said Mike Tansey, CEO of JMI. "We are extremely pleased to welcome the talented and experienced staff of these two businesses to the JMI team."

Thomson was advised by Berkery, Noyes & Co., LLC.

About Jobson Medical Information LLC: JMI is a premier integrated healthcare information and marketing services provider. Through its diversified, multi-media portfolio of marketing services, information databases, trade publications, medical education programs, events, websites and other digital and traditional media services, JMI is uniquely positioned t
'/>"/>

SOURCE Jobson Medical Information LLC
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. MSU engineering team designs innovative medical device
2. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
3. Providence St. Joseph Medical Center, Caregivers Reach Agreement on a Union Contract
4. Owner and Operator of Florida Durable Medical Equipment Company Convicted of Medicare Fraud
5. Father and Daughter From Tanzania Receive Their First Medical Examination in Newport Beach
6. Doctors and medical ethicist discuss whether doctors should participate in capital punishment
7. Preparation for Natural Disasters Critical for People With Diabetes, Chronic Medical Conditions
8. Doctors and Medical Ethicist Discuss Whether Doctors Should Participate in Capital Punishment
9. Symmetry Medical Completes Acquisition Of Specialty Surgical Instruments
10. Milestone Scientific Announces Successful Completion of its Collaboration Agreement With Carticept Medical
11. FDA Seeks to Regulate Complementary and Alternative Medicine; Products Such as Vegetable Juice Could Be Restricted for Medical Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/6/2008)... WASHINGTON, Oct. 6 /PRNewswire-USNewswire/ -- ...nst several companies alleging that they,submitted...kbacks and the,establishment of sham durable medic...nt announced today. The companies are McKesson Cor...MediNet), GGNSC Holdings LLC,Golden Gate Ancillar...
(Date:10/6/2008)... A study led by researchers at the University of ...that use of oral Vitamin D supplements bolsters pr...n the skin, and may help prevent skin infections t...most common form of eczema. , The study led by ...and chief of the Division of Dermatology at the UC...
(Date:10/6/2008)... SAN DIEGO, Oct. 6 /PRNewswire/ -- Developed in... of Pacific Palisades, CA is introducing,Revolutio...y into the,Plastic Surgery office of Dr. Steve Lav... XS-300(TM), is the first of its kind, and is base...hnology combined with,innovative proprietary softw...
(Date:10/6/2008)... Vision Audio Inc. has an...deo game designed to help train children with auti...Se Off-Road is a fun, non-violent learning experie...participate in their enhanced sound-based therapy,...dio ( http://www.easecd.com ). , ...
Breaking Medicine News(10 mins):Health News:U.S. Intervenes in False Claims Act Suit Against McKesson Corp. and Golden Horizons Nursing Homes 2Health News:Oral vitamin D may help prevent some skin infections 2Health News:Plan Your Breasts in 3-D 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 2Health News:Vision Audio Inc. Announces New EASe Games Designed for Children with Autism 3
...oger Williams has called for a ban on an artificia...tion of 6,000 types of medicines, food and drinks....he sweetener, which is used in cereal, chocolate a... Foundation has published reports that aspartame c...
...i Ramachandra Medical College and Research Institu... LifeCell have announced a joint venture towards e...lity in the city.// The umbilical cord blood stem ...ard to treating a variety of diseases. The focus o...
...licted with the Alzheimer's disease is expected to...y and the population explosion in developing natio...mentia which is connected to cardiovascular diseas...igure is expected to rise to 42 million, and to 81...
...e Mellon University have reported in the Journal P...s and being happy protects from chronic illness an...ch study was led by Professor Sheldon Cohen team w...lth as they feel that it enhances the immune syste...
Other Medicine News:
(Date:10/6/2008)...ial Showed REMICADE Therapy is More Likely to Indu...mpared with Standard Immunomod...wswire/ -- Data presented for the first time,from ...e Naive to,Immunomodulators and Biologic Therapy (...to care of patients with moderate to severe Crohn,...
(Date:10/6/2008)...netic Characteristics of Naltrexone SR Associated ...l Trials -, PHOENIX, Oct. 6 /PRNewswire-FirstCall... a biopharmaceutical company focused on the treatm...lated disorders, today presented,data showing the ...,bupropion SR), successfully achieved key objectiv...
(Date:10/5/2008)... in New England Journal of Medicine reaffirm,well-...of SPIRIVA(R),HandiHaler(R), RIDGEFIELD, Conn., a...,UPLIFT (Understanding Potential Long-term Impacts...PIRIVA(R) HandiHaler(R) (tiotropium bromide,inhala...ion for up to 4,years as measured by FEV(1) (p<0.0...
(Date:10/2/2008)...rgent PC clinical success and expanded reimburseme...APOLIS, Oct. 2 /- Uroplasty...of the first patients in a new,randomized, control...Urgent,PC neuromodulation system for the treatment...rgency, urge incontinence and frequency of urinary...
Breaking Medicine Technology:New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 2New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 3New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 4New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 5New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 6New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 7New Findings Show Efficacy of REMICADE(R) Compared With Azathioprine in Treatment of Crohn's Disease According to First-of-its Kind Study 8Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 2Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 3Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 4Orexigen(R) Therapeutics Presents Data on Its Proprietary Formulation of Naltrexone Sustained Release (SR) Used in Contrave(R) 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 2Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 3Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 4Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 5Landmark COPD Trial UPLIFT(R) Shows SPIRIVA(R) HandiHaler(R) Sustained Lung Function Improvements Over Four Years 6Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 2Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 3Uroplasty Enrolls First Patients in Urgent(R) PC Clinical Trial 4Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 1Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 2Karmanos Researchers Study the Impact of Galectin 3 on Breast Cancer Disparity in Caucasian and Asian Women 1768 3Stem Cell Marker Controls Pair of Key Cancer Pathways 16714 1Stem Cell Marker Controls Pair of Key Cancer Pathways 16714 2Celebrex Lipitor combo may halt prostate cancer 16711 1Celebrex Lipitor combo may halt prostate cancer 16711 2Celebrex Lipitor combo may halt prostate cancer 16711 3Decrease in mortality after severe injuries in accidents 16708 1
..., 2007 /PRNewswire/ -- D-Pharm announced,today tha...protective compound DP-b99 in the treatment of acu...he European Stroke,Conference. The data will be pr...or Prof. H. C. Diener, on Thursday May 31st at,14....Conference,Center in Glasgow. The abstract for the...
...RNewswire-USNewswire/ -- Evidence is,accumulating ...,reports the June 2007 issue of Harvard Women,s He...50 and over who regularly took,antidepressants cal...) had double the rate of fractures as people not u...pression itself as a source,of endocrine changes t...
Other Medicine Technology:DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 2DP-b99 Phase IIb Trial Results to be Presented at the European,Stroke Conference 3Antidepressant Use May Boost Fracture Risk, From Harvard Women's,Health Watch 2
IMMULITE and IMMULITE 1000 assays are designed for use with the IMMULITE and IMMULITE 1000, continuous random access immunoassay analyzers which offer simplicity in both design and operation. IMMULIT
The C-Reactive Protein (CRP) assay is used for the quantitative analysis of C-reactive protein in human serum and plasma. Kit is for use with the Abbot Laboratories Aeroset, ARCHITECT c8000 or ARCHI
LabDAQ3 opens new windows for the laboratory in flexibility, communication, security, and value. Users can easily move from one function to another. You can review results, validate QC, order tests,
...y for faster, easier, and more accurate automated ...lizes the latest digital FireWire technology, allo... Its ease of use allows technicians to read plates...reduction frees technicians to perform other impor...
Medicine Products: